Lenz Brian's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Aug 17, 2023
- Accession no.
- 0001140361-23-040321
- Filed
- Aug 17, 2023
- Trade date
- Aug 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 6 derivative transactions. Open-market sales total $1.77M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lenz BrianCIK 0001283260 | Officer (EVP, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | SSaleDisposed | −211,578 | $4.60F1 | −$973,258.8 | 782,013 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +97,395 | $1.67 | +$162,649.65 | 879,408 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +83,979 | $2.35 | +$197,350.65 | 963,387 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +85,416 | $2.92 | +$249,414.72 | 1,048,803 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +200,000 | $3.22 | +$644,000 | 1,248,803 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +150,000 | $3.71 | +$556,500 | 1,398,803 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +192,472 | $3.66 | +$704,447.52 | 1,591,275 | Direct | |
| Aug 15, 2023 | Common Stock | FTax withholdingDisposed | −631,078 | $4.61 | −$2,909,269.58 | 960,197 | Direct | |
| Aug 16, 2023 | Common Stock | SSaleDisposed | −178,184 | $4.45F2 | −$792,918.8 | 782,013 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −97,395 | $1.67 | −$162,649.65 | 177,605 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −83,979 | $2.35 | −$197,350.65 | 55,021 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −85,416 | $2.92 | −$249,414.72 | 14,584 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −200,000 | $3.22 | −$644,000 | 0 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −150,000 | $3.71 | −$556,500 | 0 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −192,472 | $3.66 | −$704,447.52 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.65, inclusive.
Referenced by the price of 1 transaction in Table I.
- F2
Reflects the weighted average price of sales on August 16, 2023. The shares were sold in multiple transactions at prices ranging from $4.40 to $4.535, inclusive.
Referenced by the price of 1 transaction in Table I.